Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A method for constructing retinal hemangioma-like hyperplasia and/or retinal capillary hemangioma model

A retinal blood vessel and capillary technology, applied in the field of retinal hemangioma-like hyperplasia and/or retinal capillary hemangioma model construction, can solve the problems of retarded retinal blood vessel development, retinal neovascularization without hemangioma, etc.

Active Publication Date: 2021-09-17
WEST CHINA HOSPITAL SICHUAN UNIV
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] Regarding the RCH model, since human RCH is caused by mutations in the VHL gene, Haase et al. constructed Vhl gene knockout mice in 2001 and found that Vhl- / - mice died at the embryonic stage, while Vhl+ / - mice had no RCH or Central nervous system hemangioma (Haase et al., 2001); after 2010, a variety of retinal-specific Vhl gene knockout mice were constructed, but none of them had RCH formation, but retinal vascular development was found to be delayed (Arreola et al. ,2018; Barben et al.,2018; Kurihara et al.,2010; Lange et al.,2011; Usui et al.,2015)
In 2018, Wang et al. (Wang et al., 2018) knocked out the Vhl gene in angioblasts and found that it could lead to lesions similar to early RCH, including retinal vascular dilation and vascular leakage, but no hemangioma was found in pathological examination retinal neovascularization

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A method for constructing retinal hemangioma-like hyperplasia and/or retinal capillary hemangioma model
  • A method for constructing retinal hemangioma-like hyperplasia and/or retinal capillary hemangioma model
  • A method for constructing retinal hemangioma-like hyperplasia and/or retinal capillary hemangioma model

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0029] Embodiment 1, the construction of Rb / Vhl double knockout model of the present invention

[0030] 1) Crossbreeding α-Cre mice with Vhl floxed mice, the resulting Vhl knockout mice are used as the F1 generation;

[0031] 2) The F1 generation of step 1) is crossed with the Rb floxed mouse, and the F2 generation obtained is the mouse model.

Embodiment 2

[0032] Embodiment 2, the construction of Rb / P107 / Vhl TKO model of the present invention

[0033] a) Crossbreeding α-Cre mice with Vhl floxed mice, and the Vhl knockout mice obtained as the F1 generation;

[0034] b) crossing the F1 generation of step a) with the Rb floxed mouse to obtain the F2 generation;

[0035] c) crossing the F2 generation in step b) with p107- / - mice, and the obtained F3 generation is the mouse model.

[0036] The beneficial effects of the present invention are illustrated below through test examples.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a mouse model of retinal hemangioma-like hyperplasia and / or retinal capillary hemangioma, which is a gene knockout mouse obtained by crossing Cre mice, Rb floxed mice and Vhl floxed mice. There are a large number of new blood vessels in the peripheral retina of the Rb / Vhl double knockout mouse model of the present invention, and these blood vessels penetrate the whole layer to form a dense capillary network, and lose the normal layered structure of the three-layer retinal vascular network. These phenotypes are more severe than the retinal neovascularization in the state-of-the-art RAP model; Rb / P107 / Vhl TKO mice still exhibit some neovascularization in the peripheral retina, but develop distinct stage III RAP and RCH-like lesions in the subretina .

Description

technical field [0001] The invention specifically relates to a method for constructing a model of retinal hemangioma-like hyperplasia and / or retinal capillary hemangioma. Background technique [0002] Retinal vascular disease is the most common fundus disease. Due to the unclear pathogenesis, it has always been the focus and difficulty of ophthalmology clinical work. Retinal angiomatous proliferation (RAP) and retinal capillary hemangioma (RCH) are important representatives of such diseases. Clinically, RAP is divided into three stages, including intraretinal neovascularization (stage I), subretinal neovascularization (stage II) and choroidal neovascularization (stage III). Pathologically, advanced RAP showed hemangioma-like growth, similar to RCH. [0003] RAP and RCH occur in the elderly and young adults respectively, and are very similar in pathology. The main feature is that the "tumor body" is mainly composed of vascular endothelial cells and foamy stromal cells, and ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12N15/85A01K67/027
CPCA01K67/0275A01K2217/075A01K2227/105A01K2267/0331
Inventor 陈大年肖丽容魏然孔虹雨王钰娇梁晨
Owner WEST CHINA HOSPITAL SICHUAN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products